Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02430376 · ClinicalTrials.gov registry record

dbGaP Protocol: Genetic Variants Associated With Pentalogy of Cantrell

A clinical trial of Pentalogy of Cantrell, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status
3,280
Enrollment target
1
Study location

NCT02430376 is a study of Pentalogy of Cantrell that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 3,280 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02430376, a study of Pentalogy of Cantrell, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status
3,280 participants
Enrollment target
1
Study location

Study Summary

Background: Pentalogy of Cantrell (POC) is a syndrome that involves many heart abnormalities as well as large defects in the chest and abdominal wall. This often results in the heart and other organs being present outside the body at birth. Surgeons have learned to replace them and repair the heart. Researchers want to find possible gene changes that cause POC. To do this, they want to study data from the Pediatric Cardiovascular Genetics Consortium (PCGC) Cohort. The PCGC collects data and DNA samples from people with heart diseases and their families Objectives: \- To find gene mutations in people with Pentalogy of Cantrell (POC) or other related syndromes. Eligibility: \- PCGC data and DNA samples that are open to study by the public. Design: * Researchers will study the data from the PCGC. * The gene testing being done in this study was consented to in the original studies. No new consent or waiver request is required. * The study will last 1 year.

Conditions Studied

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 3,280 participants
Start Date 2015-04-25
Est. Completion 2016-03-23

What the Registry Record Tells You About NCT02430376

The ClinicalTrials.gov registry entry for NCT02430376 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pentalogy of Cantrell appearing as the primary indexed condition, and to 0 interventions.

NCT02430376 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02430376 about?

NCT02430376 is a clinical study titled "dbGaP Protocol: Genetic Variants Associated With Pentalogy of Cantrell". Background: Pentalogy of Cantrell (POC) is a syndrome that involves many heart abnormalities as well as large defects in the chest and abdominal wall. This often results in the heart and other organs being present outside the body at birth. Surgeons have learned to replace them and repair the heart...

What is the current status of trial NCT02430376?

This trial is currently completed. The enrollment target is 3,280 participants. The study started on 2015-04-25. Estimated completion is 2016-03-23.

What conditions does trial NCT02430376 study?

This clinical trial studies the following conditions: Pentalogy of Cantrell.

Who is sponsoring clinical trial NCT02430376?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02430376 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pentalogy of Cantrell

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.